Pricing Log in Create free account

Fulgent Genetics, Inc. (FLGT) vs Exagen Inc. (XGN)

Fulgent Genetics, Inc. and Exagen Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $513.4M against $184.1M — 2.8× the size. Exagen Inc. grew revenue faster over the last twelve months: 20.8% against 4.67%. Exagen Inc. has the higher net margin (−26.6% vs −27.5%) and the lower return on invested capital (−68.3% vs −8.22%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 10 and Exagen Inc. on 8.

Valuation

Metric FLGT XGN Diagnostics & Research median
P/E n/m n/m 34.52
P/S 1.56 2.56 4.24
P/B 0.52 14.88 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 0.85 2.55 5.18
Earnings yield (16.56%) (10.77%) (1.50%)
Free cash flow yield (1.09%) (4.17%) 0.00%

Profitability

Metric FLGT XGN Diagnostics & Research median
Gross margin 33.82% 58.64% 48.32%
Operating margin (39.20%) (18.58%) (5.68%)
Net margin (27.53%) (26.61%) (4.10%)
Free cash flow margin 4.37% (10.66%) 0.00%
Return on equity (8.64%) (113.82%) 0.00%
Return on assets (7.93%) (34.19%) (6.05%)
Return on invested capital (8.22%) (68.33%) 0.00%

Growth

Metric FLGT XGN Diagnostics & Research median
Revenue growth (TTM) 4.67% 20.83% 8.99%
EPS growth (last fiscal year) (39.72%) (12.05%) 20.36%
Revenue growth, 5-year CAGR (5.21%) 9.66% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLGT XGN Diagnostics & Research median
Debt to equity 0.00 2.00 0.01
Current ratio 5.34 3.18 2.27
Net debt to EBITDA 4.66 0.68 0.68

Dividend

Metric FLGT XGN Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric FLGT XGN Diagnostics & Research median
Market cap 513.43m 184.11m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack